Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discontinuation, Efficacy, and Safety of Cholinesterase Inhibitors for Alzheimer’s Disease: a Meta-Analysis and Meta-Regression of 43 Randomized Clinical Trials Enrolling 16 106 Patients
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
Volume 20, Issue 7, Pages 519-528
Publisher
Oxford University Press (OUP)
Online
2017-02-15
DOI
10.1093/ijnp/pyx012
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis
- (2016) Andrea Cipriani et al. LANCET
- The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders:A Potential Noveltreatment?
- (2015) Won Je Jeon et al. Current Neuropharmacology
- Efficacy, safety and variability in pharmacotherapy for adults with attention deficit hyperactivity disorder: a meta-analysis and meta-regression in over 9000 patients
- (2015) R. Cunill et al. PSYCHOPHARMACOLOGY
- Systematic Review: Representativeness of Participants in RCTs of Acetylcholinesterase Inhibitors
- (2015) Anne Leinonen et al. PLoS One
- Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease
- (2014) Carina Wattmo et al. BMC Neurology
- A Systematic Review and Meta-Analysis Examining Pneumonia-Associated Mortality in Dementia
- (2014) Norine C. Foley et al. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
- Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis
- (2014) Jun Wang et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence
- (2014) R Cunill et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Long-term associations between cholinesterase inhibitors and memantine use and health outcomes among patients with Alzheimer's disease
- (2013) Carolyn W. Zhu et al. Alzheimers & Dementia
- The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease
- (2013) Peter Nordström et al. EUROPEAN HEART JOURNAL
- Combining follow-up and change data is valid in meta-analyses of continuous outcomes: a meta-epidemiological study
- (2013) Bruno R. da Costa et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Efficacy and Safety of Atomoxetine in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: Results From a Comprehensive Meta-Analysis and Metaregression
- (2013) Shimon Schwartz et al. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY
- Evolution of Heterogeneity (I2) Estimates and Their 95% Confidence Intervals in Large Meta-Analyses
- (2012) Kristian Thorlund et al. PLoS One
- Efficacy of Methylphenidate for Adults with Attention-Deficit Hyperactivity Disorder
- (2011) Xavier Castells et al. CNS DRUGS
- Randomized, Placebo-Controlled Trials of Antidepressants for Acute Major Depression: Thirty-Year Meta-Analytic Review
- (2011) Juan Undurraga et al. NEUROPSYCHOPHARMACOLOGY
- Cause of death in patients with dementia disorders
- (2009) H. R. Brunnström et al. EUROPEAN JOURNAL OF NEUROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now